Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any familial thoracic aortic aneurysm and aortic dissection in which the cause of the disease is a mutation in the MFAP5 gene.
Features include common findings: Arachnodactyly, Dural ectasia, High palate, and Aortic tortuosity; and sometimes findings: Atrial fibrillation, Pectus excavatum, Pectus carinatum, and Ascending aortic dissection and others. 11 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 5 | Thoracic aortic aneurysm, Atrial fibrillation, Aortic tortuosity |
MFAP5 encodes microfibril associated protein 5 (173 aa). May play a role in hematopoiesis. In the cardiovascular system, could regulate growth factors or participate in cell signaling in maintaining large vessel integrity. Highest expression in Nerve Tibial (238.5 TPM) and Adipose Subcutaneous (140.0 TPM).
Aortic aneurysm, familial thoracic 9 is associated with mutations in the MFAP5 gene on chromosome 12.
The MFAP5 protein participates in MFAP2, MFAP5 bind microfibrils and Fibrillins:MFAP2,MFAP5:Tropoelastin aggregate pathways.
MFAP5 is classified as a druggable target (Druggable Genome category) with score 0.0.
Genetic testing for MFAP5 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 4 common features.
No clinical trials have been registered for aortic aneurysm, familial thoracic 9.
2 publications have been identified in PubMed for aortic aneurysm, familial thoracic 9. Research spans Review / Meta-Analysis (50%) and Clinical Trial Publication (50%).
Buja LM (2025). [PMID: 40286354](https://pubmed.ncbi.nlm.nih.gov/40286354/). *JACC. Advances*. [Review / Meta-Analysis]
Eraqi M (2025). [PMID: 39557048](https://pubmed.ncbi.nlm.nih.gov/39557048/). *The Thoracic and cardiovascular surgeon*. [Clinical Trial Publication]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Growth and development |
1 |
Disproportionate tall stature |
Head and neck | 1 | High palate |